[company_age]unknown[/company_age][employees]2-10 employees[/employees][description]Forty51 Ventures is a company builder and early-stage investor in exceptional biotech companies in Europe with first-or-best-in-class potential. They source and incubate companies locally and mature them globally. Their vast and deep experience allows them to support entrepreneurs and be involved hands-on to build stronger companies faster. They are a company builder with a different DNA, considering themselves an expanded part of your team. They invest in European early-stage biotech opportunities with a clear path to the clinic, whether single-asset or platform. They are the first institutional investor in your biotech company. They bring decades of experience in the pharma industry and support entrepreneurs in their journey of venture creation. They are therapeutic area agnostic with a preference for CNS, oncology, immunology and inflammation, fibrotic disorders, and optha.[/description][ps]Company building and early-stage investment in biotech[/ps]